Table 2 Summary of tumor characteristic and finding
From: The value of [68Ga]Ga-DOTA-TATE PET/CT in diagnosis and management of suspected pituitary tumors
Patients No | Age, sex | Referral presentation | Previous treatment (PS/RT) | Tumor site/68Ga-PET/CT uptake | Final diagnosis/histology |
|---|---|---|---|---|---|
1 | 68, M | Suspected recurrent Cushing disease | PS | Pituitary fossa (SUVmax 2.3) | CD/pituitary adenoma with expression of ACTH |
2 | 37, M | Suspected recurrent Cushing disease | PS | Pituitary fossa (SUVmax 4.2 | CD/pituitary adenoma with expression of ACTH |
3 | 57, F | Suspected recurrent Cushing disease | PS | Pituitary fossa (SUVmax 4.2) | CD/atypically pituitary adenoma with expression of ACTH |
4 | 49, F | Suspected recurrent Cushing disease | PS | Pituitary fossa (SUVmax 3.1) | Pituitary adenocarcinoma with expression of ACTH |
5 | 26, M | Suspected recurrent Cushing disease | PS | Pituitary fossa (SUVmax 6.1) | CD/pituitary adenoma with expression of ACTH |
6 | 78, F | Suspected recurrent Cushing disease | PS + RT | Pancreas (SUVmax 8.4) | Pancreatic NET’s with expression of ACTH |
7 | 30, F | Suspected recurrent Cushing disease, central hyperthyroidism | PS | Pituitary fossa (SUVmax 5.2) | CD+ TSH-oma/plurihormonal pituitary adenoma with expression of TSH, FSH, and ACTH |
8 | 68, F | Suspected recurrent Cushing disease | PS | Pituitary fossa (SUVmax 3.9) | Cyclical CD/adenoma with expression of ACTH |
9 | 67, F | Suspected recurrent Cushing disease | PS | Negative | Ectopic ACTH secreting tumor, unknown source |
10 | 73, F | Ectopic Cushing syndrome | NO | Negative | Pancreatic NET’s with expression of ACTH |
11 | 14, M | Ectopic Cushing syndrome | NO | Lung nodule (SUVmax1.4) | Atypical lung carcinoid with expression ACTH |
12 | 58, M | Ectopic Cushing syndrome | NO | Lung nodule (SUVmax 1.9) | Typical lung carcinoid with expression of ACTH |
13 | 22, F | Ectopic Cushing syndrome | NO | Lung nodule (SUVmax 2.0) | Typical lung carcinoid with expression of ACTH |
14 | 42, F | Ectopic Cushing syndrome | NO | Small bowel (SUVmax 25.3) | Metastatic mid-gut NET’s with expression of ACTH |
15 | 49, F | Ectopic Cushing syndrome | NO | Head of pancreas (SUVmax 35.5 | Pancreatic NET’s with expression of ACTH |
16 | 27, M | Recurrent central hyperthyroidism | PS | Pituitary fossa (SUVmax 6.6) | TSH-Oma/pituitary adenoma with expressing of TSH |
17 | 48, M | Recurrent central hyperthyroidism | PS | Pituitary fossa (SUVmax 6.7) | TSH-Oma/pituitary adenoma with expressing of TSH |
18 | 50, F | Recurrent central hyperthyroidism | PS | Pituitary fossa (SUVmax 14.3) | TSH-Oma/pituitary adenoma with expressing of TSH |
19 | 23, M | Pituitary mass | EBRT | Pituitary fossa (SUVmax 5.5) | Prolactinoma/pituitary adenoma with expression of prolactin |
20 | 34, F | Recurrent galactorrhea | NO | Pituitary fossa (SUVmax 11.3) | Prolactinoma/pituitary adenoma with expression of prolactin |